bg
G

Greenwich Lifesciences (GLSI)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Greenwich Lifesciences (GLSI)

Greenwich LifeSciences, Inc. is a clinical stage biopharmaceutical company. The Company is developing, GP2, a breast cancer immunotherapy focused on preventing the recurrence of breast cancer following surgery. GP2 is a nine amino acid transmembrane ... Read more

  • USD12.43
  • USD12.93
  • USD11.99
  • USD21.44
  • -35.70%
  • --
  • 30.89k
  • 38.24k
  • 155M
  • 7.58
  • 12.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.